Skip navigation
Results 1 - 10 of 45 for AMIKACIN
  1. Your doctor has ordered amikacin, an antibiotic, to help treat your infection. The drug will be either injected into a large muscle (such as your ... 30 minutes, one to three times a day.Amikacin eliminates bacteria that cause many kinds of infections, ...
  2. ... valproic acid used to treat seizures Gentamicin or amikacin, antibiotics used to treat infections Testing may also ... the normal target levels: Acetaminophen: varies with use Amikacin: 15 to 25 mcg/mL Aminophylline: 10 to ...
  3. Mycobacterium Avium Complex (MAC) (New Mexico AIDS Education and Training Center)  
    ... common MAC drugs and their side effects are: Amikacin (Amkin): kidney and ear problems; taken as an ...
  4. ... the kidneys include cyclosporine (Neoral, Sandimmune); aminoglycosides including amikacin (Amikin), gentamicin (Garamycin, Gentak, others), and tobramycin (Nebcin, ...
  5. ... that may be used to treat TB include: Amikacin Ethionamide Moxifloxacin Para-aminosalicylic acid Streptomycin You may ...
  6. Reported Tuberculosis in the United States, 2012 (Centers for Disease Control and Prevention)  
    ... injectable second-line anti-TB drugs (i.e., amikacin, kanamycin, or capreomycin). 2,3 Two cases were ...
  7. ... might cause muscle problems. Some aminoglycoside antibiotics include amikacin (Amikin), gentamicin (Garamycin), kanamycin (Kantrex), streptomycin, tobramycin (Nebcin), ...
  8. ... Ethambutol Other drugs that may be used include: Amikacin Ethionamide Moxifloxacin Para-aminosalicylic acid Streptomycin You may ...
  9. Extensively Drug-Resistant Tuberculosis (XDR TB) (Centers for Disease Control and Prevention)  
    ... of three injectable second-line drugs (i.e., amikacin, kanamycin, or capreomycin). MDR TB is caused by ...
  10. Tuberculosis Information for International Travelers (Centers for Disease Control and Prevention)  
    ... of three injectable second-line drugs (i.e., amikacin, kanamycin, or capreomycin). Because XDR TB is resistant ...
previous · 1 · 2 · 3 · 4 · 5 · next